Background & Aims
Introduction: The oral Anti-inflammatory have been previously demonstrated to be effective in Arthritis of shoulders. In addition, an exagerated local inflammatory reaction was also described, secondary to tissue lesion. Objective:The study evaluated the efficacy of local Patch of Lidocaine combined to oral Anti-Inflammatory analgesia in Arthritis of shoulders .
Methods
Materials and Methods: After ethical approval and patient consent, 30 patients with Arthritis of shoulders were divided into two groups. The Control group (CG) received both Patch without Lidocaine more oral anti-inflammatory, oral ketoprofen 150mg/day, and the Study group (SG) received similar oral anti-inflammatory doses to the CG, more Lidocaine Patch for a 02 ( two ) weeks compared to the CG. The Anti-inflammatory was done the same doses and hours to boths groups, and the Patchs was done during 12 ( twelve ) consecutives hours every day. Analgesia was evaluated through the 10 cm VAS and rescue analgesic consumption. P<0.05 was considered significant.
Results
Only the Study Group showed lesser rescue analgesic consumption after the first week, and smaller VAS scales after the second week evaluation (p<0.05). The comparison among groups revealed less ketoprofen consumption 7 and 14 days after use of Lidocaine Patch compared to the CG (p<0.05
Conclusions
Diversely from oral anti-inflamatory alone, the analgesia was more effective when the antiinflammatory agent was combined to lidocaine Patch in Arthritis of Shoulders.
References
Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs. 2004;64(9):937-47.
41
Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother. 2002;36(2):236-40.
42
Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237-51.
43
Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc. 2015;90(4):532-45.
44
Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65(1):39-44.
45
Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves post-herpetic neuralgia more effectively than vehicle patch: results of an enriched enrolment study. Pain. 1999;80(3):533-8.
46
Katz NP, Davis MW, Dworkin RH. Topical lidocaine patch produces a significant improvement in mean pain scores and pain relief in treated PHN patients: results of a multicenter open-label trial. J Pain. 2001;2(1):9-18.
47
Meier T, Wasner G, Faust M, Kuntzer T, Ochsner F, Hueppe M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain. 2003;106(1e2):151-8.
48
de Le?n-Casasola OA, Mayoral V. The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence. J Pain Res. 2016;9(1):67-79
“
Presenting Author
Izabel Lima
Poster Authors
IZABEL LIMA
MD PhD
Sao Francisco hospital Hapvida
Lead Author
Topics
- Treatment/Management: Complementary and Alternative therapies